logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 부산지방법원 2013.12.19 2013고정5072
약사법위반등
Text

Defendant shall be punished by a fine of 1.5 million won.

If the defendant does not pay the above fine, 50,000 won shall be one day.

Reasons

Punishment of the crime

The defendant is a person who operates a pharmacy with a trade name "D Pharmacy" in Gangseo-gu Busan Metropolitan Government C.

No one shall manufacture, sell, manufacture, or sell any goods bearing a trademark identical with or similar to another person's registered trademark, carry them for the purpose of sale, sell, acquire for the purpose of sale, store or display any forged medicine, and no pharmacy founder shall sell prescription drugs except where he/she prepares drugs in accordance with the prescriptions given by a doctor or a dentist.

Nevertheless, the Defendant purchased, possessed, and possessed, for the purpose of sale, a “Calalalce,” the same forged trademark as “Calis,” which is registered with the Korean Intellectual Property Office as the medicine, etc. for treatment as above, from sale in which the name of the above pharmacy cannot be known at the above pharmacy, and then sold, around May 31, 2013, approximately 40,000, the above “Calalty,” known to the customer E at the above pharmacy around 15:03, and kept, around 13:05, the above pharmacy for the purpose of selling, approximately 40,00,00, the above “Calty,” known to the customer.

Summary of Evidence

1. Defendant's legal statement;

1. Notification of detection of pharmacies violating the Pharmaceutical Affairs Act;

1. Each protocol of seizure, each list of seizure, and submission at will;

1. The application of Acts and subordinate statutes to the investigation report (as to the attachment of a copy of the statement), investigation report (as to the attachment of the trademark register of eggs), investigation report (as to the attachment of the attorney-at-law letter and the attorney-law letter of attorney-at-law), investigation report ( as to the attachment of photographs of the purchasing contracting party and the user contracting party), investigation report ( as to the attachment of the photographs of the purchasing contracting party), each investigation report (as to the results of the appraisal of the (as to the notification of the (as to the attachment of the (as to the (as to the (as to the (as to the (i) notification on the (as to the (i) notification, (ii) notification on the (as to the

1. Article 93 of the Trademark Act and Article 93 of the Pharmaceutical Affairs Act concerning criminal facts.

arrow